Cts CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
CTS Corporation's July 2026 investor presentation outlines a strategy focused on diversified end markets, technological innovation, and strategic M&A to achieve a 10% CAGR.
NYSE
CTS Corporation announced robust second quarter 2026 financial results, driven by strong diversification momentum, leading to record margins and an increased full-year outlook.
NYSE
CTS Corporation appoints Pratik Trivedi as President and CEO, effective July 6, 2026, as Kieran O'Sullivan transitions to Executive Chairman.
NYSE
CTS Corporation announced the results of its Annual Meeting of Shareholders held on May 14, 2026, with all director nominees elected and key proposals approved.
NYSE
CTS Corporation's April 2026 investor presentation outlines a strategy focused on diversified end-market growth, technological innovation, and strategic acquisitions, targeting a 10% CAGR.
NYSE
CTS Corporation announced robust first-quarter 2026 financial results, driven by significant growth in diversified end markets, and has narrowed its full-year guidance.
NYSE
CTS Corporation outlines a strategy for 10% organic and inorganic growth, driven by diversification into industrial, medical, and aerospace & defense markets, alongside new product innovations.
NYSE
CTS Corporation announced strong fourth quarter and full-year 2025 results, driven by significant growth in diversified end markets, despite a decline in the transportation sector.
NYSE
CTS Corporation announced the resignation of Senior Vice President Martin Baumeister and the appointment of Pratik Trivedi as Chief Operating Officer, effective December 5, 2025.
NYSE
CTS Corporation and its subsidiary, CTS Denmark Holding A/S, entered into a new five-year, $300 million unsecured revolving credit facility, replacing a previous $400 million facility.
NYSE
CTS Corporation announced the expansion of its Board of Directors and the appointment of Kimberly MacKay, a seasoned executive from West Pharmaceutical Services, Inc., effective November 5, 2025.
NYSE
CTS Corporation presented its October 2025 investor update, emphasizing strong performance in diversified markets, strategic M&A, and a positive long-term growth outlook.
NYSE
CTS Corporation announced third quarter 2025 results, showcasing strong growth in diversified end markets while facing challenges in the transportation sector, and updated its full-year guidance.
NYSE
CTS Corporation's latest investor presentation highlights robust financial performance, strategic diversification into high-growth end markets, and a strong outlook for 2025, driven by megatrends and disciplined capital allocation.
NYSE
CTS Corporation announced robust second quarter 2025 financial results, featuring double-digit sales growth in diversified end markets and expanded adjusted EBITDA margins, despite a decline in the transportation sector.
NYSE
CTS Corporation announced the appointment of Mark Pacioni, an executive with over 30 years of legal experience, as its new Chief Legal & Administrative Officer and Corporate Secretary, effective July 1, 2025.
NYSE
CTS Corporation successfully held its Annual Meeting of Shareholders on May 8, 2025, electing all director nominees and approving Proposals 2 and 3.
NYSE
CTS Corporation presented an investor presentation in April 2025, outlining its growth strategy, diversified market approach, and financial performance, including LTM revenue of $515 million and adjusted EPS of $2.09.
NYSE
CTS Corporation reports flat overall sales for Q1 2025, but highlights a 14% increase in sales to diversified end-markets.
NYSE
Scott D'Angelo, Vice President, Chief Legal and Administrative Officer, and Corporate Secretary of CTS Corporation, has resigned, effective April 4, 2025, to pursue another opportunity.
NYSE
CTS Corporation presented its investor presentation in February 2025, outlining its growth strategy, financial performance, and future outlook, including guidance for fiscal year 2025 and strategic M&A activities.
NYSE
CTS Corporation reports a 2% increase in Q4 sales and a 6% decrease in full-year sales for 2024, highlighting growth in diversified markets offset by transportation sector softness.
NYSE
CTS Corporation presented its growth strategy, financial performance, and market outlook in an investor presentation, highlighting diversification and strategic acquisitions.
NYSE
CTS Corporation announced improved third-quarter earnings and stronger cash flow, despite a slight year-over-year revenue decrease, while also updating its full-year sales guidance.
NYSE
CTS Corporation's principal accounting officer, Thomas White, has resigned effective September 18, 2024, to pursue a new opportunity, with Ashish Agrawal, the CFO, stepping in as his replacement.
NYSE
CTS Corporation presented its growth strategy, financial performance, and market outlook in an investor presentation, highlighting diversification and strategic acquisitions.
NYSE
CTS Corporation reported second quarter 2024 results, achieving earnings in line with expectations despite transportation market softness, and announced the acquisition of SyQwest, LLC.
NYSE
CTS Corporation's Board of Directors approved minor bylaw amendments and held its annual shareholder meeting, electing directors and approving proposals.
NYSE
CTS Corporation presented its growth strategy, financial performance, and market outlook in an investor presentation, highlighting diversification and strategic acquisitions.
NYSE
CTS Corporation announced first quarter 2024 results with sales down 14% year-over-year but showing some sequential improvement, alongside a decrease in net income.